Company
 |
INVESTOR
Unidym Investor Relations 1430 O'Brien Drive, Suite G Menlo Park, CA 94025 Tel: 650.462.1935 Fax: 650.462.1939 Email: info@unidym.com Key investors are the following:  Arrowhead Research Corporation is a publicly-traded nanotechnology company commercializing new technologies in the areas of
life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of its majority-owned
subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source
early-stage deals and to generate intellectual property covering promising new nanotechnologies. At present, Arrowhead has four
subsidiaries commercializing nanotechnology products and applications: Insert Therapeutics (drug delivery of anti-cancer therapeutics),
Calando Pharmaceuticals (drug delivery of RNAi therapeutics), Unidym (carbon-based electronics),
Tego BioSciences and Aonex Technologies
(compound semiconductor materials).
 BattelleBattelle brings an unrivaled range of technological and scientific expertise to solve significant national and global problems. From the national laboratories they oversee, to the research and development they perform, to the products they help usher to market, Battelle serves more than 800 federal, state and governmental agencies, some of the largest corporations in the world and the private sector. Through offices in more than a 100 national and international locations they conduct $3.9 billion in annual research and development. www.battelle.org  Tokyo ElectronAs a leading global supplier of semiconductor production equipment, Tokyo Electron Limited (TEL) engages in development, manufacturing, and sales in a wide range of product fields. The company also leverages specialized technologies developed for the semiconductor production equipment market to engage in the area of flat panel display (FPD) production equipment. All of TEL's semiconductor and FPD production equipment product lines maintain high market shares in their respective global segments. http://www.tel.com |